PT Kalbe Farma Tbk. (PTKFF)

USD 0.08

(0.0%)

Net Income Summary of PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk.'s latest annual net income in 2023 was 179.7 Million USD , down -16.92% from previous year.
PT Kalbe Farma Tbk.'s latest quarterly net income in 2024 Q3 was 37.83 Million USD , down -26.81% from previous quarter.
PT Kalbe Farma Tbk. reported an annual net income of 216.46 Million USD in 2022, down -2.87% from previous year.
PT Kalbe Farma Tbk. reported an annual net income of 222.85 Million USD in 2021, up 14.56% from previous year.
PT Kalbe Farma Tbk. reported a quarterly net income of 37.83 Million USD for 2024 Q3, down -26.81% from previous quarter.
PT Kalbe Farma Tbk. reported a quarterly net income of 60.32 Million USD for 2024 Q1, up 32.24% from previous quarter.

Annual Net Income Chart of PT Kalbe Farma Tbk. (2023 - 2015)

Historical Annual Net Income of PT Kalbe Farma Tbk. (2023 - 2015)

Year	Net Income	Net Income Growth
2023	179.7 Million USD	-16.92%
2022	216.46 Million USD	-2.87%
2021	222.85 Million USD	14.56%
2020	194.53 Million USD	7.74%
2019	180.57 Million USD	5.68%
2018	170.87 Million USD	-3.55%
2017	177.15 Million USD	3.78%
2016	170.69 Million USD	17.41%
2015	145.39 Million USD	0.0%

Year	Net Income	Net Income Growth
2024 Q2	51.69 Million USD	-14.3%
2024 Q3	37.83 Million USD	-26.81%
2024 Q1	60.32 Million USD	32.24%
2023 Q4	45.61 Million USD	30.95%
2023 FY	179.83 Million USD	-16.92%
2023 Q1	56.47 Million USD	-1.59%
2023 Q2	45.1 Million USD	-20.13%
2023 Q3	34.83 Million USD	-22.78%
2022 Q2	53.73 Million USD	-6.72%
2022 FY	216.46 Million USD	-2.87%
2022 Q4	57.38 Million USD	4.05%
2022 Q3	55.15 Million USD	2.64%
2022 Q1	57.6 Million USD	-8.14%
2021 Q1	49.32 Million USD	0.0%
2021 FY	222.85 Million USD	14.56%
2021 Q4	62.71 Million USD	13.34%
2021 Q3	55.33 Million USD	2.75%
2021 Q2	53.84 Million USD	9.17%
2020 FY	194.53 Million USD	7.74%
2019 FY	180.57 Million USD	5.68%
2018 FY	170.87 Million USD	-3.55%
2017 FY	177.15 Million USD	3.78%
2016 FY	170.69 Million USD	17.41%
2015 FY	145.39 Million USD	0.0%

Peer Net Income Comparison of PT Kalbe Farma Tbk.

Name	Net Income	Net Income Difference
AstraZeneca PLC	5.95 Billion USD	96.982%
Bristol-Myers Squibb Company PFD CONV 2	8.02 Billion USD	97.761%
CSPC Pharmaceutical Group Limited	830.91 Million USD	78.373%
Clarus Therapeutics Holdings, Inc.	-56.51 Million USD	417.995%
Novartis AG	14.85 Billion USD	98.79%